Quantitative analysis of nanoparticle transport through in vitro blood-brain barrier models

References

• Sanhai WR, Sakamoto JH, Canady R, Ferrari M. Seven challenges for nanomedicine. Nat Nanotechnol 2008; 3:242-4; PMID:18654511; http://dx.doi.org/10.1038/nnano.2008.114
   PubMed Web of Science ®Google Scholar
• Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano 2009; 3:16-20; PMID:19206243; http://dx.doi.org/10.1021/nn90-0002m
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. Nanomedicine: Current status and future prospects. FASEB J 2005; 19:311-30; PMID:15746175; http://dx.doi.org/10.1096/fj.04-2747rev
   PubMed Web of Science ®Google Scholar
• Couvreur P. Nanoparticles in drug delivery: Past, present and future. Adv Drug Deliv Rev 2013; 65:21-3; PMID:22580334; http://dx.doi.org/10.1016/j.addr.2012.04.010
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 2011; 63:136-51; PMID:20441782; http://dx.doi.org/10.1016/j.addr.2010.04.009
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986; 46:6387-92; PMID:2946403
   PubMed Web of Science ®Google Scholar
• Ferrari M. Cancer nanotechnology: Opportunities and challenges. Nat Rev Cancer 2005; 5:161-71; PMID:15738981; http://dx.doi.org/10.1038/nrc1566
   PubMed Web of Science ®Google Scholar
• Ruoslahti E, Bhatia SN, Sailor MJ. Targeting of drugs and nanoparticles to tumors. J Cell Biol 2010; 188:759-68; PMID:20231381; http://dx.doi.org/10.1083/jcb.200910104
   PubMed Web of Science ®Google Scholar
• Andrieux K, Garcia-Garcia E, Kim HR, Couvreur P. Colloidal carriers: A promising way to treat central nervous system diseases. J Nanoneurosci 2009; 1:17-34; http://dx.doi.org/10.1166/jns.2009.003
   Google Scholar
• Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 2001; 47:65-81; PMID:11251246; http://dx.doi.org/10.1016/S0169-409X(00)00122-8
   PubMed Web of Science ®Google Scholar
• Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 2012; 64:213-22; http://dx.doi.org/10.1016/j.addr.2012.09.015
   Web of Science ®Google Scholar
• Begley DJ. Delivery of therapeutic agents to the central nervous system: The problems and the possibilities. Pharmacol Ther 2004; 104:29-45; PMID:15500907; http://dx.doi.org/10.1016/j.pharmthera.2004.08.001
   PubMed Web of Science ®Google Scholar
• Pardridge WM. Blood–brain barrier delivery. Drug Discov Today 2007; 12:54-61; PMID:17198973; http://dx.doi.org/10.1016/j.drudis.2006.10.013
   PubMed Web of Science ®Google Scholar
• Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 2004; 377:159-69; PMID:14505488; http://dx.doi.org/10.1042/bj20031253
   PubMed Web of Science ®Google Scholar
• Chithrani BD, Ghazani AA, Chan WCW. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006; 6:662-8; PMID:16608261; http://dx.doi.org/10.1021/nl052396o
   PubMed Web of Science ®Google Scholar
• Salvati A, Åberg C, dos Santos T, Varela J, Pinto P, Lynch I, Dawson KA. Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: Toward models of uptake kinetics. Nanomedicine Nanotechnol Biol Med 2011; 7:818-26; http://dx.doi.org/10.1016/j.nano.2011.03.005
   PubMed Web of Science ®Google Scholar
• Ulbrich K, Hekmatara T, Herbert E, Kreuter J. Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB). Eur J Pharm Biopharm 2009; 71:251-6; PMID:18805484; http://dx.doi.org/10.1016/j.ejpb.2008.08.021
   PubMed Web of Science ®Google Scholar
• Chang J, Jallouli Y, Kroubi M, Yuan X, Feng W, Kang C, Pu P, Betbeder D. Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood–brain barrier. Int J Pharm 2009; 379:285-92; PMID:19416749; http://dx.doi.org/10.1016/j.ijpharm.2009.04.035
   PubMed Web of Science ®Google Scholar
• Kreuter J, Shamenkov D, Petrov V, Ramge P, Cychutek K, Koch-Brandt C, Alyautdin R. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target 2002; 10:317-25; PMID:12164380; http://dx.doi.org/10.1080/10611860290031877
   PubMed Web of Science ®Google Scholar
• Kim H, Gil S, Andrieux K, Nicolas V, Appel M, Chacun H, Desmaële D, Taran F, Georgin D, Couvreur P. Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells. Cell Mol Life Sci 2007; 64:356-64; PMID:17256088; http://dx.doi.org/10.1007/s00018-007-6390-x
   PubMed Web of Science ®Google Scholar
• Zensi A, Begley D, Pontikis C, Legros C, Mihoreanu L, Wagner S, Büchel C, von Briesen H, Kreuter J. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. J Controlled Release 2009; 137:78-86; http://dx.doi.org/10.1016/j.jconrel.2009.03.002
   PubMed Web of Science ®Google Scholar
• Wagner S, Zensi A, Wien SL, Tschickardt SE, Maier W, Vogel T, Worek F, Pietrzik CU, Kreuter J, von Briesen H. Uptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model. PLoS ONE 2012; 7:e32568; PMID:22396775; http://dx.doi.org/10.1371/journal.pone.0032568
   PubMed Web of Science ®Google Scholar
• Reimold I, Domke D, Bender J, Seyfried CA, Radunz H-E, Fricker G. Delivery of nanoparticles to the brain detected by fluorescence microscopy. Eur J Pharm Biopharm 2008; 70:627-32; PMID:18577452; http://dx.doi.org/10.1016/j.ejpb.2008.05.007
   PubMed Web of Science ®Google Scholar
• Kumar P, Wu H, McBride JL, Jung K-E, Hee Kim M, Davidson BL, Kyung Lee S, Shankar P, Manjunath N. Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007; 448:39-43; PMID:17572664; http://dx.doi.org/10.1038/nature05901
   PubMed Web of Science ®Google Scholar
• Demeule M, Régina A, Ché C, Poirier J, Nguyen T, Gabathuler R, Castaigne J-P, Béliveau R. Identification and design of peptides as a new drug delivery system for the brain. J Pharmacol Exp Ther 2008; 324:1064-72; PMID:18156463; http://dx.doi.org/10.1124/jpet.107.131318
   PubMed Web of Science ®Google Scholar
• Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005; 113:823-39; PMID:16002369; http://dx.doi.org/10.1289/ehp.7339
   PubMed Web of Science ®Google Scholar
• Nel A, Xia T, Mädler L, Li N. Toxic potential of materials at the nanolevel. Science 2006; 311:622-7; PMID:16456071; http://dx.doi.org/10.1126/science.1114397
   PubMed Web of Science ®Google Scholar
• Donaldson K, Stone V, Tran CL, Kreyling W, Borm PJA. Nanotoxicology. Occup Environ Med 2004; 61:727-8; PMID:15317911; http://dx.doi.org/10.1136/oem.2004.013243
   PubMed Web of Science ®Google Scholar
• Shvedova AA, Kagan VE, Fadeel B. Close encounters of the small kind: Adverse effects of man-made materials interfacing with the nano-cosmos of biological systems. Annu Rev Pharmacol Toxicol 2010; 50:63-88; PMID:20055698; http://dx.doi.org/10.1146/annurev.pharmtox.010909.105819
   PubMed Web of Science ®Google Scholar
• Rivera-Gil P, Jimenez De Aberasturi D, Wulf V, Pelaz B, Del Pino P, Zhao Y, De La Fuente JM, Ruiz De Larramendi I, Rojo T, Liang X-J, et al. The challenge to relate the physicochemical properties of colloidal nanoparticles to their cytotoxicity. Acc Chem Res 2013; 46:743-9; PMID:22786674; http://dx.doi.org/10.1021/ar300039j
   PubMed Web of Science ®Google Scholar
• Valsami-Jones E, Lynch I. How safe are nanomaterials? Science 2015; 350:388-9; PMID:26494749; http://dx.doi.org/10.1126/science.aad0768
   PubMed Web of Science ®Google Scholar
• Oberdörster G, Elder A, Rinderknecht A. Nanoparticles and the brain: Cause for concern? J Nanosci Nanotechnol 2009; 9:4996-5007; PMID:19928180; http://dx.doi.org/10.1166/jnn.2009.GR02
   PubMed Web of Science ®Google Scholar
• Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 2004; 16:437-45; PMID:15204759; http://dx.doi.org/10.1080/08958370490439597
   PubMed Web of Science ®Google Scholar
• Kreyling WG, Semmler-Behnke M, Seitz J, Scymczak W, Wenk A, Mayer P, Takenaka S, Oberdörster G. Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol 2009; 21 Suppl 1:55-60; PMID:19558234; http://dx.doi.org/10.1080/08958370902942517
   PubMedGoogle Scholar
• Abbott NJ, Dolman DEM, Yusof SR, Reichel A. In vitro models of CNS barriers. In: Hammarlund-Udenaes M, Lange ECM de, Thorne RG, editors. Drug Delivery to the Brain. New York: Springer; 2014. page 163-97.
   Google Scholar
• Audus KL, Borchardt RT. Characterization of an in vitro blood–brain barrier model system for studying drug transport and metabolism. Pharm Res 1986; 3:81-7; PMID:24271465; http://dx.doi.org/10.1023/A:1016337202335
   PubMed Web of Science ®Google Scholar
• Shaw DJ. Introduction to colloid and surface chemistry. 4th ed. Oxford: Butterworth-Heinemann; 1992. 306 p.
   Google Scholar
• Schübbe S, Cavelius C, Schumann C, Koch M, Kraegeloh A. STED microscopy to monitor agglomeration of silica particles inside A549 cells. Adv Eng Mater 2010; 12:417-22; http://dx.doi.org/10.1002/adem.201000093
   Web of Science ®Google Scholar
• Wang Z, Tiruppathi C, Minshall RD, Malik AB. Size and dynamics of caveolae studied using nanoparticles in living endothelial cells. ACS Nano 2009; 3:4110-6; PMID:19919048; http://dx.doi.org/10.1021/nn9012274
   PubMed Web of Science ®Google Scholar
• Bramini M, Ye D, Hallerbach A, Nic Raghnaill M, Salvati A, Åberg C, Dawson KA. Imaging approach to mechanistic study of nanoparticle interactions with the blood-brain barrier. ACS Nano 2014; 8:4304-12; PMID:24773217; http://dx.doi.org/10.1021/nn5018523
   PubMed Web of Science ®Google Scholar
• Ye D, Nic Raghnaill M, Bramini M, Mahon E, Åberg C, Salvati A, Dawson KA. Nanoparticle accumulation and transcytosis in brain endothelial cell layers. Nanoscale 2013; 5:11153-65; PMID:24077327; http://dx.doi.org/10.1039/c3nr02905k
   PubMed Web of Science ®Google Scholar
• Georgieva JV, Kalicharan D, Couraud P-O, Romero IA, Weksler B, Hoekstra D, Zuhorn IS. Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood-brain barrier endothelial cells in vitro. Mol Ther 2011; 19:318-25; PMID:21045812; http://dx.doi.org/10.1038/mt.2010.236
   PubMed Web of Science ®Google Scholar
• Gulson B, Wong H. Stable isotopic tracing—a way forward for nanotechnology. Environ Health Perspect 2006; 114:1486-8; PMID:17035130; http://dx.doi.org/10.1289/ehp.9277
   PubMed Web of Science ®Google Scholar
• Gibson N, Holzwarth U, Abbas K, Simonelli F, Kozempel J, Cydzik I, Cotogno G, Bulgheroni A, Gilliland D, Ponti J, et al. Radiolabelling of engineered nanoparticles for in vitro and in vivo tracing applications using cyclotron accelerators. Arch Toxicol 2011; 85:751-73; PMID:21479952; http://dx.doi.org/10.1007/s00204-011-0701-6
   PubMed Web of Science ®Google Scholar
• Aktaş Y, Yemisci M, Andrieux K, Gürsoy RN, Alonso MJ, Fernandez-Megia E, Novoa-Carballal R, Quiñoá E, Riguera R, Sargon MF, et al. Development and brain delivery of chitosan−PEG nanoparticles functionalized with the monoclonal antibody OX26. Bioconjug Chem 2005; 16:1503-11; PMID:16287248; http://dx.doi.org/10.1021/bc050217o
   PubMed Web of Science ®Google Scholar
• Zensi A, Begley D, Pontikis C, Legros C, Mihoreanu L, Büchel C, Kreuter J. Human serum albumin nanoparticles modified with apolipoprotein A-I cross the blood-brain barrier and enter the rodent brain. J Drug Target 2010; 18:842-8; PMID:20849354; http://dx.doi.org/10.3109/1061186X.2010.513712
   PubMed Web of Science ®Google Scholar
• Elsaesser A, Taylor A, de Yanés GS, McKerr G, Kim E-M, O'Hare E, Howard CV. Quantification of nanoparticle uptake by cells using microscopical and analytical techniques. Nanomed 2010; 5:1447-57; http://dx.doi.org/10.2217/nnm.10.118
   PubMed Web of Science ®Google Scholar
• Sartori A, Gatz R, Beck F, Rigort A, Baumeister W, Plitzko JM. Correlative microscopy: Bridging the gap between fluorescence light microscopy and cryo-electron tomography. J Struct Biol 2007; 160:135-45; PMID:17884579; http://dx.doi.org/10.1016/j.jsb.2007.07.011
   PubMed Web of Science ®Google Scholar
• Monopoli MP, Åberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 2012; 7:779-86; PMID:23212421; http://dx.doi.org/10.1038/nnano.2012.207
   PubMed Web of Science ®Google Scholar
• Cedervall T, Lynch I, Lindman S, Berggård T, Thulin E, Nilsson H, Dawson KA, Linse S. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A 2007; 104:2050-5; PMID:17267609; http://dx.doi.org/10.1073/pnas.0608582104
   PubMed Web of Science ®Google Scholar
• Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 2009; 61:428-37; PMID:19376175; http://dx.doi.org/10.1016/j.addr.2009.03.009
   PubMed Web of Science ®Google Scholar
• Walkey CD, Chan WCW. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev 2012; 41:2780-99; PMID:22086677; http://dx.doi.org/10.1039/C1CS15233E
   PubMed Web of Science ®Google Scholar
• Hellstrand E, Lynch I, Andersson A, Drakenberg T, Dahlbäck B, Dawson KA, Linse S, Cedervall T. Complete high-density lipoproteins in nanoparticle corona. FEBS J 2009; 276:3372-81; PMID:19438706; http://dx.doi.org/10.1111/j.1742-4658.2009.07062.x
   PubMed Web of Science ®Google Scholar
• Kapralov AA, Feng WH, Amoscato AA, Yanamala N, Balasubramanian K, Winnica DE, Kisin ER, Kotchey GP, Gou P, Sparvero LJ, et al. Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration. ACS Nano 2012; 6:4147-56; PMID:22463369; http://dx.doi.org/10.1021/nn300626q
   PubMed Web of Science ®Google Scholar
• Gasser M, Rothen-Rutishauser B, Krug HF, Gehr P, Nelle M, Yan B, Wick P. The adsorption of biomolecules to multi-walled carbon nanotubes is influenced by both pulmonary surfactant lipids and surface chemistry. J Nanobiotechnology 2010; 8:31; PMID:21159192; http://dx.doi.org/10.1186/1477-3155-8-31
   PubMed Web of Science ®Google Scholar
• Raesch SS, Tenzer S, Storck W, Rurainski A, Selzer D, Ruge CA, Perez-Gil J, Schaefer UF, Lehr C-M. Proteomic and lipidomic analysis of nanoparticle corona upon contact with lung surfactant reveals differences in protein, but not lipid composition. ACS Nano 2015; 9:11872-85; PMID:26575243; http://dx.doi.org/10.1021/acsnano.5b04215
   PubMed Web of Science ®Google Scholar
• Zeng Z, Patel J, Lee S-H, McCallum M, Tyagi A, Yan M, Shea KJ. Synthetic polymer nanoparticle–polysaccharide interactions: A systematic study. J Am Chem Soc 2012; 134:2681-90; PMID:22229911; http://dx.doi.org/10.1021/ja209959t
   PubMed Web of Science ®Google Scholar
• Wan S, Kelly PM, Mahon E, Stöckmann H, Rudd PM, Caruso F, Dawson KA, Yan Y, Monopoli MP. The “sweet” side of the protein corona: Effects of glycosylation on nanoparticle–cell interactions. ACS Nano 2015; 9:2157-66; PMID:25599105; http://dx.doi.org/10.1021/nn506060q
   PubMed Web of Science ®Google Scholar
• Martel J, Young D, Young A, Wu C-Y, Chen C-D, Yu J-S, Young JD. Comprehensive proteomic analysis of mineral nanoparticles derived from human body fluids and analyzed by liquid chromatography–tandem mass spectrometry. Anal Biochem 2011; 418:111-25; PMID:21741946; http://dx.doi.org/10.1016/j.ab.2011.06.018
   PubMed Web of Science ®Google Scholar
• Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Baldelli Bombelli F, Dawson KA. Physical−chemical aspects of protein corona: Relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 2011; 133:2525-34; PMID:21288025; http://dx.doi.org/10.1021/ja107583h
   PubMed Web of Science ®Google Scholar
• Tenzer S, Docter D, Rosfa S, Wlodarski A, Kuharev J, Rekik A, Knauer SK, Bantz C, Nawroth T, Bier C, et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: A comprehensive quantitative proteomic analysis. ACS Nano 2011; 5:7155-67; PMID:21866933; http://dx.doi.org/10.1021/nn201950e
   PubMed Web of Science ®Google Scholar
• Walczyk D, Baldelli Bombelli F, Monopoli MP, Lynch I, Dawson KA. What the cell “sees” in bionanoscience. J Am Chem Soc 2010; 132:5761-8; PMID:20356039; http://dx.doi.org/10.1021/ja910675v
   PubMed Web of Science ®Google Scholar
• Milani S, Baldelli Bombelli F, Pitek AS, Dawson KA, Rädler J. Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: Soft and hard corona. ACS Nano 2012; 6:2532-41; PMID:22356488; http://dx.doi.org/10.1021/nn204951s
   PubMed Web of Science ®Google Scholar
• Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes V. Time evolution of the nanoparticle protein corona. ACS Nano 2010; 4:3623-32; PMID:20553005; http://dx.doi.org/10.1021/nn901372t
   PubMed Web of Science ®Google Scholar
• Kim HR, Andrieux K, Delomenie C, Chacun H, Appel M, Desmaële D, Taran F, Georgin D, Couvreur P, Taverna M. Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip® system. Electrophoresis 2007; 28:2252-61; PMID:17557357; http://dx.doi.org/10.1002/elps.200600694
   PubMed Web of Science ®Google Scholar
• Hamad I, Al-Hanbali O, Hunter AC, Rutt KJ, Andresen TL, Moghimi SM. Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere−serum interface: Implications for stealth nanoparticle engineering. ACS Nano 2010; 4:6629-38; PMID:21028845; http://dx.doi.org/10.1021/nn101990a
   PubMed Web of Science ®Google Scholar
• Dai Q, Walkey C, Chan WCW. Polyethylene glycol backfilling mitigates the negative impact of the protein corona on nanoparticle cell targeting. Angew Chem Int Ed 2014; 53:5093-6; http://dx.doi.org/10.1002/anie.201408375
   PubMed Web of Science ®Google Scholar
• Pelaz B, del Pino P, Maffre P, Hartmann R, Gallego M, Rivera-Fernández S, de la Fuente JM, Nienhaus GU, Parak WJ. Surface functionalization of nanoparticles with polyethylene glycol: Effects on protein adsorption and cellular uptake. ACS Nano 2015; 9:6996-7008; PMID:26079146; http://dx.doi.org/10.1021/acsnano.5b01326
   PubMed Web of Science ®Google Scholar
• Barrán-Berdón AL, Pozzi D, Caracciolo G, Capriotti AL, Caruso G, Cavaliere C, Riccioli A, Palchetti S, Laganà A. Time evolution of nanoparticle–protein corona in human plasma: Relevance for targeted drug delivery. Langmuir 2013; 29:6485-94; http://dx.doi.org/10.1021/la401192x
   PubMed Web of Science ®Google Scholar
• Ritz S, Schöttler S, Kotman N, Baier G, Musyanovych A, Kuharev J, Landfester K, Schild H, Jahn O, Tenzer S, et al. Protein corona of nanoparticles: Distinct proteins regulate the cellular uptake. Biomacromolecules 2015; 16:1311-21; PMID:25794196; http://dx.doi.org/10.1021/acs.biomac.5b00108
   PubMed Web of Science ®Google Scholar
• Doorley GW, Payne CK. Cellular binding of nanoparticles in the presence of serum proteins. Chem Commun 2011; 47:466; http://dx.doi.org/10.1039/C0CC02618B
   PubMed Web of Science ®Google Scholar
• Doorley GW, Payne CK. Nanoparticles act as protein carriers during cellular internalization. Chem Commun 2012; 48:2961-3; http://dx.doi.org/10.1039/c2cc16937a
   PubMed Web of Science ®Google Scholar
• Wang F, Yu L, Monopoli MP, Sandin P, Mahon E, Salvati A, Dawson KA. The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. Nanomedicine Nanotechnol Biol Med 2013; 9:1159-68; http://dx.doi.org/10.1016/j.nano.2013.04.010
   PubMed Web of Science ®Google Scholar
• Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci 2008; 105:14265-70; PMID:18809927; http://dx.doi.org/10.1073/pnas.0805135105
   PubMed Web of Science ®Google Scholar
• Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin RF. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology 2009; 20:455101; PMID:19822937; http://dx.doi.org/10.1088/0957-4484/20/45/455101
   PubMed Web of Science ®Google Scholar
• Lück M. Plasmaproteinadsorption als möglicher Schlüsselfaktor für eine kontrollierte Arzneistoffapplikation mit partikulären Trägern [dissertation]. [Berlin]: Freie Universität Berlin; 1997. 174 p.
   Google Scholar
• Alyaudtin R, Gothier D, Petrov V, Kharkevich D, Kreuter J. Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles. Eur J Pharm Biopharm 1995; 41:44-8
   Web of Science ®Google Scholar
• Lundqvist M, Stigler J, Cedervall T, Berggård T, Flanagan MB, Lynch I, Elia G, Dawson K. The evolution of the protein corona around nanoparticles: A test study. ACS Nano 2011; 5:7503-9; PMID:21861491; http://dx.doi.org/10.1021/nn202458g
   PubMed Web of Science ®Google Scholar
• Kim JA, Salvati A, Åberg C, Dawson KA. Suppression of nanoparticle cytotoxicity approaching in vivo serum concentrations: Limitations of in vitro testing for nanosafety. Nanoscale 2014; 6:14180-4; PMID:25340311; http://dx.doi.org/10.1039/C4NR04970E
   PubMed Web of Science ®Google Scholar
• Lesniak A, Federico Fenaroli, Monopoli MP, Åberg C, Dawson KA, Salvati A. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 2012; 6:5845-57; PMID:22721453; http://dx.doi.org/10.1021/nn300223w
   PubMed Web of Science ®Google Scholar
• Ge C, Du J, Zhao L, Wang L, Liu Y, Li D, Yang Y, Zhou R, Zhao Y, Chai Z, et al. Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc Natl Acad Sci 2011; 108:16968-73; PMID:21969544; http://dx.doi.org/10.1073/pnas.1105270108
   PubMed Web of Science ®Google Scholar
• Hu W, Peng C, Lv M, Li X, Zhang Y, Chen N, Fan C, Huang Q. Protein corona-mediated mitigation of cytotoxicity of graphene oxide. ACS Nano 2011; 5:3693-700; PMID:21500856; http://dx.doi.org/10.1021/nn200021j
   PubMed Web of Science ®Google Scholar
• Lesniak A, Salvati A, Santos-Martinez MJ, Radomski MW, Dawson KA, Åberg C. Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J Am Chem Soc 2013; 135:1438-44; PMID:23301582; http://dx.doi.org/10.1021/ja309812z
   PubMed Web of Science ®Google Scholar
• Bhabra G, Sood A, Fisher B, Cartwright L, Saunders M, Evans WH, Surprenant A, Lopez-Castejon G, Mann S, Davis SA, et al. Nanoparticles can cause DNA damage across a cellular barrier. Nat Nanotechnol 2009; 4:876-83; PMID:19893513; http://dx.doi.org/10.1038/nnano.2009.313
   PubMed Web of Science ®Google Scholar
• Sood A, Salih S, Roh D, Lacharme-Lora L, Parry M, Hardiman B, Keehan R, Grummer R, Winterhager E, Gokhale PJ, et al. Signalling of DNA damage and cytokines across cell barriers exposed to nanoparticles depends on barrier thickness. Nat Nanotechnol 2011; 6:824-33; PMID:22056725; http://dx.doi.org/10.1038/nnano.2011.188
   PubMed Web of Science ®Google Scholar
• Nic Raghnaill M, Bramini M, Ye D, Couraud P-O, Romero IA, Weksler B, Åberg C, Salvati A, Lynch I, Dawson KA. Paracrine signalling of inflammatory cytokines from an in vitro blood brain barrier model upon exposure to polymeric nanoparticles. Analyst 2014; 139:923-30; PMID:24195103; http://dx.doi.org/10.1039/C3AN01621H
   PubMed Web of Science ®Google Scholar
• Limbach LK, Wick P, Manser P, Grass RN, Bruinink A, Stark WJ. Exposure of engineered nanoparticles to human lung epithelial cells:  Influence of chemical composition and catalytic activity on oxidative stress. Environ Sci Technol 2007; 41:4158-63; PMID:17612205; http://dx.doi.org/10.1021/es062629t
   PubMed Web of Science ®Google Scholar
• McCormick SM, Eskin SG, McIntire LV, Teng CL, Lu C-M, Russell CG, Chittur KK. DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells. Proc Natl Acad Sci 2001; 98:8955-60; PMID:11481467; http://dx.doi.org/10.1073/pnas.171259298
   PubMed Web of Science ®Google Scholar
• Chen BPC, Li Y-S, Zhao Y, Chen K-D, Li S, Lao J, Yuan S, Shyy JY-J, Chien S. DNA microarray analysis of gene expression in endothelial cells in response to 24-h shear stress. Physiol Genomics 2001; 7:55-63; PMID:11595792; http://dx.doi.org/10.1006/geno.2001.6511
   PubMed Web of Science ®Google Scholar
• Cucullo L, Hossain M, Puvenna V, Marchi N, Janigro D. The role of shear stress in blood-brain barrier endothelial physiology. BMC Neurosci 2011; 12:40; PMID:21569296; http://dx.doi.org/10.1186/1471-2202-12-40
   PubMed Web of Science ®Google Scholar
• Klingberg H, Loft S, Oddershede LB, Møller P. The influence of flow, shear stress and adhesion molecule targeting on gold nanoparticle uptake in human endothelial cells. Nanoscale 2015; 7:11409-19; PMID:26077188; http://dx.doi.org/10.1039/C5NR01467K
   PubMed Web of Science ®Google Scholar
• Han J, Zern BJ, Shuvaev VV, Davies PF, Muro S, Muzykantov V. Acute and chronic shear stress differently regulate endothelial internalization of nanocarriers targeted to platelet-endothelial cell adhesion molecule-1. ACS Nano 2012; 6:8824-36; PMID:22957767; http://dx.doi.org/10.1021/nn302687n
   PubMed Web of Science ®Google Scholar
• Bhowmick T, Berk E, Cui X, Muzykantov VR, Muro S. Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1. J Controlled Release 2012; 157:485-92; http://dx.doi.org/10.1016/j.jconrel.2011.09.067
   PubMed Web of Science ®Google Scholar
• Decuzzi P, Ferrari M. Design maps for nanoparticles targeting the diseased microvasculature. Biomaterials 2008; 29:377-84; PMID:17936897; http://dx.doi.org/10.1016/j.biomaterials.2007.09.025
   PubMed Web of Science ®Google Scholar
• Decuzzi P, Pasqualini R, Arap W, Ferrari M. Intravascular delivery of particulate systems: Does geometry really matter? Pharm Res 2008; 26:235-43; PMID:18712584; http://dx.doi.org/10.1007/s11095-008-9697-x
   PubMed Web of Science ®Google Scholar
• Velve-Casquillas G, Le Berre M, Piel M, Tran PT. Microfluidic tools for cell biological research. Nano Today 2010; 5:28-47; PMID:21152269; http://dx.doi.org/10.1016/j.nantod.2009.12.001
   PubMed Web of Science ®Google Scholar
• Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol 2014; 32:760-72; PMID:25093883; http://dx.doi.org/10.1038/nbt.2989
   PubMed Web of Science ®Google Scholar